Sanofi (SNYNF) stock
SNYNFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SNY
$78.48−0.07 (-0.09%)
Close on Oct 19, 2026Market cap $191.40BP/E 22.1Yield –
Sanofi operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was €10.75B, up 18.4% from the year before. Over ten years it grew 2.6% a year on average. The highest annual figure on record is €10.75B in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €10.75B | +18.4% |
| FY2024 | Dec 31, 2024 | €9.08B | -11.5% |
| FY2023 | Dec 31, 2023 | €10.26B | -2.5% |
| FY2022 | Dec 31, 2022 | €10.53B | +0.0% |
| FY2021 | Dec 31, 2021 | €10.52B | +41.8% |
| FY2020 | Dec 31, 2020 | €7.42B | -3.8% |
| FY2019 | Dec 31, 2019 | €7.72B | +39.1% |
| FY2018 | Dec 31, 2018 | €5.55B | -24.8% |
| FY2017 | Dec 31, 2017 | €7.38B | -5.9% |
| FY2016 | Dec 31, 2016 | €7.84B | -5.5% |
| FY2015 | Dec 31, 2015 | €8.29B | – |
See a number that looks wrong?